Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Evaxion Biotech A/S
EVAX
Healthcare
Biotechnology
Evaxion Biotech A/S is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is...
developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:EVAX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(267)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Sep 26, 2024 11:18am
Evaxion significantly expands vaccine development collaborat
Just In: $EVAX Evaxion significantly expands vaccine development collaboration with MSDAgreement provides MSD with options to license Evaxion@s preclinical, AI-designed vaccine candidates EVX-B2 and
...more
(267)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 01, 2024 1:15pm
Evaxion Biotech Announces Pricing of $15 Million Public Offe
Breaking News: $EVAX Evaxion Biotech Announces Pricing of $15 Million Public Offering | BenzingaCOPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ:EVAX) ("Evaxion
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(267)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 24, 2024 10:00am
Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales | Benz
Just In: $EVAX Dow Jumps 100 Points; Netflix Reports Strong Q4 Sales | BenzingaU.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Wednesday.Following the
...more
(267)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Jan 22, 2024 3:15pm
EVAX announced stock split 1-10
Breaking News: $EVAX EVAX announced stock split 1-102024-01-22 08:02:10 ET Evaxion Biotech A/S (EVAX) announced stock split at a ratio of 1-for-10 on 2024-01-22 ... Full story available on
...more
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Feb 08, 2023 8:34am
EVAX ...early a.m runner up on NR
Evaxion and Pantherna announce promising preclinical mRNA vaccine data 2023-02-08 03:30 ET - News Release COPENHAGEN, Denmark and HENNIGSDORF, Germany, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Evaxion
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Oct 05, 2022 8:32am
New Press Release - Evaxion welcomes Per Norlén as new CEO.
COPENHAGEN, Denmark, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, announces that its new Chief Executive Officer (CEO) Per Norlén has joined...
read article.
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 3:52pm
EVAX ....8 mins to close....still time for Mr. Maggot to
turn this red ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 2:54pm
EVAX ..... L.O.D
Now what Mr. Facking Maggot Me no position...just watching your style ; )
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 2:42pm
EVAX ...say "Goodnight Dyck"
This is done.....I will be surprised if it doesn't go red
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 1:54pm
EVAX ..... I strongly believe this deal is done
Volume is too low and the trend is not your friend. I took a small loss on a small position Stops protect portfolios....this bounce u r seeing .....Don't fall for it $2.87 resistance
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 1:45pm
EVAX ..... Mr. Maggot beat everyone again
Madda pakka
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 1:14pm
EVAX ...sh8t happens
Stps protect portfolios
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 1:09pm
EVAX ...pop u maddapakka !!!!
Come on !!!!
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 12:53pm
EVAX ....still "range bound"
This need a volume spike or it's game over...done like dinner Wait for it with a stop in place
(72)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Sep 21, 2022 10:48am
EVAX .... The break of $3.09 at 7:08 (1minchart)
then went into PB mode and established 2x's bottom on that last PB to $2.87....a little rally ensued but couldn't break res at $3.09 I see this should be "range bound" or sideways
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >